Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 74.47

-2.1%

Nov 13 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1539)	2/6/2006 4:38:11 PM
From: Jibacoa	Read Replies (1) of 3722

YMI closed near its intraday H bigcharts.marketwatch.com It is also having some help from comments by Gene Marcial on the last issue of Busness Week where he mentioned that YMI could have a winner in its Tesmilifene for metastatic breast Ca and also mentions that Mitchell Kaye of Xmark Capital has a "target" of $15 for the stock as he thinks that Tesmilifene could have a market of $1B if approved.<g> YMI also expects to have some benefits from its AeroLef, which is a formulation of both free and liposome-encapsulated fentanyl administered by inhalation and is on a PII for pain relief for Ca victims. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next